According to a report published by Nikkei Asia on Tuesday, the upcoming Apple Watch Series 7 will include blood pressure measurement capabilities, which is one of the reasons why the device’s production has hit snags as manufacturers adjust to the more complex design.
Later that day, Bloomberg cited its own sources to back up Nikkei’s main claim that the new model had caused manufacturing issues that could result in supply constraints or shipment delays, but the subsequent report by Debbie Wu and Mark Gurman made no mention of Nikkei’s claim that a blood pressure sensor was one of the causes of the production snags.
If there was any doubt, Gurman has now put it to rest in a tweet, saying that the Apple Watch Series 7 will have “no chance” of having a blood pressure sensor.
That’s not to say that a future Apple Watch model won’t include blood pressure monitoring capabilities. Apple was revealed to be the largest customer of Rockley Photonics, a British electronics start-up that develops non-invasive optical sensors for detecting multiple blood-related health metrics such as blood pressure, blood glucose, and blood alcohol levels, earlier this year.
As the company prepared to go public in New York, Rockley revealed that Apple is its largest client. Given Rockley Photonics’ rapid growth and the scope of Apple’s partnership with the company, it seems almost certain that the company’s health sensor technology will make its way into the Apple Watch at some point, albeit not this year.
Apple is widely expected to hold an all-digital event in the middle of this month to unveil the iPhone 13 and Apple Watch Series 7, the latter of which is expected to feature a new flat-edged design, larger case sizes, a faster processor, and battery upgrades. Check out our Apple Watch rumor roundup for all the details.